Listen

treating COVID-19

Jo ingles

In the wake of President Trump's diagnosis with COVID-19 and brief hospitalization, medical experts and elected officials are analyzing his treatment and behavior.  

Just as the coronavirus pandemic began its rapid and deadly spread across the United States, a well-known doctor named Dominique Fradin-Read told thousands of viewers tuning into an Instagram Live video that she had an answer: "one of the best ways to prevent and fight COVID-19."

Researchers at Ohio State University's Medical Center are seeking applications from 500 adults to participate in a clinical trial of a COVID-19 vaccine. 

koamnewsnow.com

University Hospitals in Cleveland has been tapped to help test a potential COVID-19 vaccine.  

cnet.com

The Ohio Board of Pharmacy has reversed it's decsion to ban the use of hydroxychloroquine for treating COVID-19, after governor Mike DeWine called for a more thorough invetigation of the drug touted by his fellow Republican, President Trump. 

Ohio Governor Mike DeWine is asking the state Board of Pharmacy to reconsider a ban on prescribing hydroxychloroquine to treat COVID-19.

cnet.com

The drug that had been touted by President Trump as a treatment for COVID-19 is being banned in Ohio. 

The National Institutes of Health has halted its study of hydroxychloroquine, a drug President Donald Trump has promoted as a possible treatment for COVID-19 and once claimed to be taking himself.

In a statement issued on Saturday, the agency said that although it did not appear hydroxychloroquine caused harm to patients in the study, it was also "very unlikely to be beneficial."

George Floyd’s murder on Memorial Day weekend at the hands of Minneapolis officer Derick Chauvin and his three supporting officers has re-engergized the Black Lives Matter movement. While police brutality is the movement's central focus, addressing broader health disparities is a critical part of racial justice.

reuters.com

The Ohio Senate has rejected an Ohio House bill requiring people with COVID-19 give consent to contact tracing in writing. 

Taking hydroxychloroquine after being exposed to someone with COVID-19 does not protect someone from getting the disease.

That's the conclusion of a study published Wednesday involving 821 participants. All had direct exposure to a COVID-19 patient, either because they lived with one, or were a health care provider or first responder.

During her 17 years running Okanogan County's small public health department in eastern Washington, Lauri Jones rarely encountered any controversy.

"Usually, we kind of sit here under the radar," says Jones, whose department before the pandemic was mostly known for mundane duties such as recording births, issuing permits for septic tanks, and investigating reports of food poisoning.

Updated at 11:16 p.m. ET

The Food and Drug Administration is cautioning the public about the reliability of a widely used rapid test for the coronavirus. The test, made by Abbott Laboratories, has been linked with inaccurate results that could falsely reassure patients that they are not infected with the virus.

The Trump administration has promoted the test as a key factor in controlling the epidemic in the U.S., and it's used for daily testing at the White House.

washingtonpost.com

The Ohio Department of Health and the Ohio Hospital Association will distribute remdesivir, an unproven antiviral treatment for COVID-19. 

Gilead Sciences, the drugmaker behind the experimental COVID-19 treatment remdesivir, spent more on lobbying Congress and the administration in the first quarter of 2020 than it ever has before, according to federal filings.

The pharmaceutical company spent $2.45 million on lobbying in the first three months of the year, a 32% increase over the $1.86 million it spent in the first quarter of 2019.

Updated at 4:59 p.m. ET

The Food and Drug Administration has given emergency use authorization to the antiviral drug remdesivir to treat hospitalized patients with the coronavirus, President Trump on Friday told reporters at the White House.

Gilead CEO Daniel O'Day said remdesivir maker Gilead Sciences is donating 1.5 million vials of the drug and will work with the federal government to distribute it to patients in need.